Skip to content

Ultrasound and Electromyography Biofeedback for Pelvic Floor Muscle Training

Application of Simultaneous Pelvic Floor Ultrasonography and Electromyography Biofeedback on Pelvic Floor Muscle Training

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07243028
Enrollment
70
Registered
2025-11-21
Start date
2024-02-29
Completion date
2028-12-31
Last updated
2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Floor Dysfunction, Pelvic Floor Muscle Weakness

Keywords

Pelvic floor dysfunction, Pelvic floor muscle training, Health behavior, Biofeedback

Brief summary

This study aims to investigate the factors influencing adherence to pelvic floor muscle training (PFMT) devices among patients with pelvic floor dysfunction (PFD) through structured questionnaires, while simultaneously comparing the effectiveness of different feedback modalities, including non-invasive ultrasound imaging and invasive manometry with electromyography (EMG). By integrating subjective adherence data with objective performance outcomes, the project seeks to evaluate the potential of system-level integration for personalized therapeutic strategies, ultimately enhancing treatment efficacy, improving patient satisfaction, and promoting sustained engagement in PFMT.

Interventions

DEVICEUltrasound Biofeedback Device

Application of trans-abdominal ultrasonography as a biofeedback tool during pelvic floor muscle training

DEVICEManometer Biofeedback Device

Application of manometry as a biofeedback tool during pelvic floor muscle training. The manometer is a routinely used clinical device in hospital-based pelvic floor rehabilitation programs to provide quantitative intravaginal pressure feedback and guide patients in performing correct pelvic floor muscle contractions.

Sponsors

National Cheng-Kung University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Women aged 21 years or older diagnosed with pelvic floor muscle dysfunction and requiring pelvic floor muscle training (e.g., for symptomatic pelvic organ prolapse, stress urinary incontinence, or dysfunctional voiding). 2. A Pelvic Floor Disability Index (PFDI-20) score greater than 1. 3. Ability and willingness to provide written informed consent and authorization for the release of personal health information. 4. Willingness and ability to complete all required questionnaires

Exclusion criteria

1. Individuals planning a future pregnancy. 2. Inability to read, understand, or sign the written consent form prior to participation.

Design outcomes

Primary

MeasureTime frameDescription
Bladder base displacement (cm) during pelvic floor muscle contractions measured by transabdominal ultrasoundBaseline and at each of the six pelvic floor muscle training sessions (Sessions 1-6). The six training sessions will be completed within approximately one month, and study parameters will be measured at each of these six sessions by the research staff.Transabdominal ultrasound imaging will be employed to provide real-time visualization and quantitative assessment of bladder base displacement during pelvic floor muscle (PFM) contractions. The displacement of the bladder base (in centimeters) will be recorded. Data will be aggregated as mean ± standard deviation.
Change in bladder base angle (degrees) relative to the horizontal line during pelvic floor muscle contractions measured by transabdominal ultrasoundBaseline and at each of the six pelvic floor muscle training sessions (Sessions 1-6). The six training sessions will be completed within approximately one month, and study parameters will be measured at each of these six sessions by the research staff.Transabdominal ultrasound imaging will be used to quantify the angular change of the bladder base relative to a horizontal reference line during pelvic floor muscle (PFM) contractions. The angle (in degrees) at rest and during contraction will be recorded, and the difference will be calculated. Data will be summarized as mean ± standard deviation across participants for each session.
Survey on Willingness to Use Pelvic Floor Muscle Training DevicesA total of six pelvic floor muscle training sessions will be completed within approximately one month. Questionnaires will be administered at the 3rd session (midpoint of the treatment) and the 6th session (completion of all training sessions)A structured questionnaire designed to assess participants' willingness to use pelvic floor muscle training (PFMT) devices. The survey evaluates multiple domains, including both physical and psychological aspects, providing insights into patient adherence and acceptance of different pelvic floor muscle training (PFMT) assistive tools. The questionnaire is based on a 7-point Likert scale, ranging from 1 (strongly disagree) to 7 (strongly agree). Higher scores indicate greater willingness, acceptance, and positive perception toward the use of pelvic floor muscle training devices.

Secondary

MeasureTime frameDescription
Surface ElectromyographyAt each of the six pelvic floor muscle training sessions (Sessions 1-6). The six training sessions will be completed within approximately one month, and outcome parameters will be measured at each of these six sessions by the research staff.Electromyographic signals of pelvic floor muscle contractions will be recorded using the wireless surface EMG system.
Vaginal manometry measurementMeasurements will be performed during either the 1st to 3rd sessions (approximately days 1-14 after baseline) or the 4th to 6th sessions (approximately days 15-30 after baseline), according to each participant's assigned randomization sequence.A pressure-sensing probe will be inserted vaginally to measure intravaginal pressure (expressed in cmH₂O) generated during pelvic floor muscle contractions.

Countries

Taiwan

Contacts

Primary ContactLi-Chieh Kuo, Ph. D.
jkkuo@mail.ncku.edu.tw886-62353535

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026